Evidence map›Paper›PMID 32021684›Full record

ReviewCell & bioscience2020

H3K36me3, message from chromatin to DNA damage repair.

Zhongxing Sun, Yanjun Zhang, Junqi Jia, Yuan Fang, Yin Tang, Hongfei Wu, Dong Fang

Open access · goldAbstract readReview
In one paragraph

Review in Cell & bioscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Many faces of mammalian NSD methyltransferases.Cellular & molecular biology letters · 2026
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zhongxing Sun *Life Sciences Institute, Zhejiang University, Hangzhou, 310058 Zhejiang China.
Yanjun Zhang *Life Sciences Institute, Zhejiang University, Hangzhou, 310058 Zhejiang China.
Junqi JiaLife Sciences Institute, Zhejiang University, Hangzhou, 310058 Zhejiang China.
Yuan FangLife Sciences Institute, Zhejiang University, Hangzhou, 310058 Zhejiang China.
Yin TangLife Sciences Institute, Zhejiang University, Hangzhou, 310058 Zhejiang China.
Hongfei WuLife Sciences Institute, Zhejiang University, Hangzhou, 310058 Zhejiang China.
Dong FangLife Sciences Institute, Zhejiang University, Hangzhou, 310058 Zhejiang China.ORCID 0000-0002-9807-5224
Zhejiang International Studies University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histone marks control many cellular processes including DNA damage repair. This review will focus primarily on the active histone mark H3K36me3 in the regulation of DNA damage repair and the maintenance of genomic stability after DNA damage. There are diverse clues showing H3K36me3 participates in DNA damage response by directly recruiting DNA repair machinery to set the chromatin at a "ready" status, leading to a quick response upon damage. Reduced H3K36me3 is associated with low DNA repair efficiency. This review will also place a main emphasis on the H3K36me3-mediated DNA damage repair in the tumorigenesis of the newly found oncohistone mutant tumors. Gaining an understanding of different aspects of H3K36me3 in DNA damage repair, especially in cancers, would share the knowledge of chromatin and DNA repair to serve to the drug discovery and patient care.

Indexed as

Acute myeloid leukemiaClear cell renal cell carcinomaDiffuse intrinsic pontine gliomaDNA damageDNA mismatch repairH3K36me3Homologous recombinationNonhomologous end-joiningOncohistones

Identifiers

PMID32021684
PMCPMC6995143
OpenAlexW3008360793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.